Viewing Study NCT06957561


Ignite Creation Date: 2025-12-24 @ 1:04 PM
Ignite Modification Date: 2026-01-22 @ 9:24 PM
Study NCT ID: NCT06957561
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-04
First Post: 2025-04-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module